Michael A. Irvine

4.1k total citations
100 papers, 2.5k citations indexed

About

Michael A. Irvine is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Michael A. Irvine has authored 100 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Infectious Diseases, 29 papers in Epidemiology and 20 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Michael A. Irvine's work include COVID-19 epidemiological studies (13 papers), SARS-CoV-2 and COVID-19 Research (10 papers) and Opioid Use Disorder Treatment (10 papers). Michael A. Irvine is often cited by papers focused on COVID-19 epidemiological studies (13 papers), SARS-CoV-2 and COVID-19 Research (10 papers) and Opioid Use Disorder Treatment (10 papers). Michael A. Irvine collaborates with scholars based in Canada, United Kingdom and United States. Michael A. Irvine's co-authors include Valerie Voon, Neil A. Harrison, T. Déirdre Hollingsworth, Edward T. Bullmore, Paula Banca, Yulia Worbe, Laurel Morris, Trevor W. Robbins, Daniel Coombs and Simon Mitchell and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Michael A. Irvine

89 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael A. Irvine Canada	25	691	585	535	485	331	100	2.5k
Tomoko Udo United States	21	1.3k 1.9×	1.4k 2.4×	529 1.0×	295 0.6×	134 0.4×	41	3.7k
Stéphanie Baggio Switzerland	30	732 1.1×	354 0.6×	193 0.4×	599 1.2×	221 0.7×	173	2.8k
Katarzyna Wyka United States	29	773 1.1×	456 0.8×	287 0.5×	391 0.8×	211 0.6×	121	2.8k
Christian Holm Hansen United Kingdom	27	451 0.7×	799 1.4×	452 0.8×	264 0.5×	647 2.0×	101	3.8k
Mei‐Chen Hu United States	31	915 1.3×	130 0.2×	637 1.2×	693 1.4×	170 0.5×	99	3.2k
Jennifer L. Brown United States	33	468 0.7×	1.1k 1.8×	669 1.3×	838 1.7×	93 0.3×	175	3.6k
Aleksandar Kecojević United States	22	531 0.8×	232 0.4×	285 0.5×	430 0.9×	85 0.3×	44	1.9k
Tyson H. Holmes United States	34	379 0.5×	338 0.6×	222 0.4×	1.6k 3.3×	147 0.4×	76	4.2k
Martha Anker Switzerland	15	697 1.0×	264 0.5×	281 0.5×	143 0.3×	230 0.7×	20	2.7k
Enrique R. Pouget United States	33	394 0.6×	782 1.3×	658 1.2×	1.6k 3.4×	246 0.7×	81	3.0k

Countries citing papers authored by Michael A. Irvine

Since Specialization

Citations

This map shows the geographic impact of Michael A. Irvine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Irvine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Irvine more than expected).

Fields of papers citing papers by Michael A. Irvine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Irvine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Irvine. The network helps show where Michael A. Irvine may publish in the future.

Co-authorship network of co-authors of Michael A. Irvine

This figure shows the co-authorship network connecting the top 25 collaborators of Michael A. Irvine. A scholar is included among the top collaborators of Michael A. Irvine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael A. Irvine. Michael A. Irvine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Doyle, Carla M., Jesse Knight, Linwei Wang, et al.. (2025). Impact of interventions on mpox transmission during the 2022 outbreak in Canada: a mathematical modeling study of three different cities. International Journal of Infectious Diseases. 153. 107792–107792. 2 indexed citations

Watts, Allison W., Sirui Li, Michael A. Irvine, et al.. (2025). Chronic health consequences of the COVID-19 pandemic on school workers: a cross-sectional post-pandemic analysis. BMJ Open. 15(7). e095685–e095685.

Irvine, Michael A., et al.. (2024). Estimating the total utilization of take home naloxone during an unregulated drug toxicity crisis: A Bayesian modeling approach. International Journal of Drug Policy. 128. 104454–104454. 1 indexed citations

Touloupou, Panayiota, Claudio Fronterrè, Jorge Cano, et al.. (2024). An Ensemble Framework for Projecting the Impact of Lymphatic Filariasis Interventions Across Sub-Saharan Africa at a Fine Spatial Scale. Clinical Infectious Diseases. 78(Supplement_2). S108–S116. 3 indexed citations

Cox, Joseph, Daniel Grace, Trevor Hart, et al.. (2024). Characteristics of the Sexual Networks of Men Who Have Sex With Men in Montréal, Toronto, and Vancouver: Insights from Canada's 2022 Mpox Outbreak. The Journal of Infectious Diseases. 229(Supplement_2). S293–S304. 2 indexed citations

Watts, Allison W., Felicity Clemens, Michael A. Irvine, et al.. (2024). Risk of Reinfection and Incidence of Chronic Symptoms After SARS-CoV-2 Infections. Open Forum Infectious Diseases. 11(10). ofae608–ofae608.

Gilbert, Mark, Aidan Ablona, Hsiu-Ju Chang, et al.. (2023). Uptake of Mpox vaccination among transgender people and gay, bisexual and other men who have sex with men among sexually-transmitted infection clinic clients in Vancouver, British Columbia. Vaccine. 41(15). 2485–2494. 23 indexed citations

Irvine, Michael A., Natalie Prystajecky, Hind Sbihi, et al.. (2023). Emergence of SARS-CoV-2 Delta Variant and Effect of Nonpharmaceutical Interventions, British Columbia, Canada. Emerging infectious diseases. 29(10). 1999–2007. 1 indexed citations

Irvine, Michael A., et al.. (2023). EPS1.07 Impact of elexacaftor/tezacaftor/ivacaftor (ETI) therapy on Aspergillus fumigatus serology in adults with cystic fibrosis. Journal of Cystic Fibrosis. 22. S39–S39. 1 indexed citations

10.

Stockdale, Jessica E., Sean C. Anderson, Andrew M. Edwards, et al.. (2022). Quantifying transmissibility of SARS-CoV-2 and impact of intervention within long-term healthcare facilities. Royal Society Open Science. 9(1). 211710–211710. 3 indexed citations

11.

Iyaniwura, Sarafa A., Prince Adu, Marsha Taylor, et al.. (2022). Mathematical modeling of COVID-19 in British Columbia: An age-structured model with time-dependent contact rates. Epidemics. 39. 100559–100559. 16 indexed citations

12.

Skowronski, Danuta M., Michael A. Irvine, Shinhye Kim, et al.. (2022). Serial cross-sectional estimation of vaccine-and infection-induced SARS-CoV-2 seroprevalence in British Columbia, Canada. Canadian Medical Association Journal. 194(47). E1599–E1609. 38 indexed citations

13.

Irvine, Michael A., et al.. (2021). Usability of Virtual Visits for the Routine Clinical Care of Trans Youth during the COVID-19 Pandemic: Youth and Caregiver Perspectives. International Journal of Environmental Research and Public Health. 18(21). 11321–11321. 8 indexed citations

14.

Nama, Nassr, et al.. (2021). Conservative and surgical modalities in the management of paediatric parapneumonic effusion and empyema: a protocol for a living systematic review and network meta-analysis. BMJ Open. 11(3). e045010–e045010. 2 indexed citations

15.

Collyer, Benjamin, Michael A. Irvine, T. Déirdre Hollingsworth, Mark Bradley, & Roy M. Anderson. (2020). Defining a prevalence level to describe the elimination of Lymphatic Filariasis (LF) transmission and designing monitoring & evaluating (M&E) programmes post the cessation of mass drug administration (MDA). PLoS neglected tropical diseases. 14(10). e0008644–e0008644. 17 indexed citations

16.

Min, Jeong Eun, Lindsay A Pearce, Fahmida Homayra, et al.. (2020). Estimates of opioid use disorder prevalence from a regression-based multi-sample stratified capture-recapture analysis. Drug and Alcohol Dependence. 217. 108337–108337. 16 indexed citations

17.

Anderson, Sean C., Andrew M. Edwards, Jessica E. Stockdale, et al.. (2020). Quantifying the impact of COVID-19 control measures using a Bayesian model of physical distancing. PLoS Computational Biology. 16(12). e1008274–e1008274. 53 indexed citations

18.

Davis, Christopher N., T. Déirdre Hollingsworth, Quentin Caudron, & Michael A. Irvine. (2020). The use of mixture density networks in the emulation of complex epidemiological individual-based models. PLoS Computational Biology. 16(3). e1006869–e1006869. 21 indexed citations

19.

Fisk, Helena L., Michael A. Irvine, Elizabeth A. Miles, et al.. (2018). Association of oily fish intake, sex, age, BMI andAPOEgenotype with plasma long-chainn-3 fatty acid composition. British Journal Of Nutrition. 120(1). 23–32. 14 indexed citations

20.

Irvine, Michael A., et al.. (2017). MOSQUITO BITE HETEROGENEITY INFLUENCES LYMPHATIC FILARIASIS PREVALENCE, INTENSITY AND OPPORTUNITIES FOR CONTROL. American Journal of Tropical Medicine and Hygiene. 95. 346–346. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact